Session

Back to Programme Overview

Why do we form stones and how can we prevent them?

Poster Session 01

  • Location:
    Room Milan, North Hall (Level 1)
  • Chairs:
     G. Gambaro, Rome (IT)
     A. Skolarikos, Athens (GR)
  • Aims and objectives of this session

    The stone is not the disease! Unraveling the epidemiology and pathomechanisms of renal stone formation should be the aim of stone research. A thorough understanding of why crystals are retained is necessary to improve preventive concepts.

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.
1
Geographical and prevalence trends in urolithiasis in England: A ten-year review

By: Ni Raghallaigh H., Ellis D., Symes A.

Institutes: Brighton & Sussex Univeristy Hospitals Nhs Trust, Dept. of Urology, Brighton, United Kingdom

2
24-hour urine parameters and body mass index in a large cohort of high risk renal stone formers patients

By: Esperto F.1, Marangella M.2, Miano R.3, Trinchieri A.4

Institutes: 1Sapienza University, Sant’andrea Hospital, Dept. of Urology, Rome, Italy, 2Mauritian’s Order Hospital, Dept. of Nephrology, Turin, Italy, 3Policlinico Tor Vergata Foundation, University of Rome Tor Vergata, Dept. of Urology, Rome, Italy, 4Lecco’s Hospital, Dept. of Urology, Lecco, Italy

3
Twelve-hour overnight urine as a new tool to assess the urinary crystallization risk: Preliminary results

By: Casasayas Carles P.1, Rodriguez Garcia N.1, Rodriguez A.2, Saez-Torres C.2, Gutierrez-Sanz-Gadea C.1, Grases F.2

Institutes: 1Hospital Son Llatzer, Dept. of Urology, Palma de Mallorca, Spain, 2Universitat De Les Illes Balears, Laboratory of Kidney Stone Research. University Institute of Health Science Research (IUNICS-IdISPa), Palma de Mallorca, Spain

4
Hyperuricemia or uric-acid stone; which increases the risk of renal function deterioration?

By: Tanaka T., Htakeyama S., Terayama Y., Saitoh F., Saitoh H., Yamamoto H., Imai A., Yoneyama T., Hashimoto Y., Koie T., Ohyama C.

Institutes: Hirosaki University Graduate School of Medicine, Dept. of Urology, Hirosaki, Japan

5
Urolithiasis is an independent risk factor for fracture: A nation-wide population-based study with an 8-year follow-up

By: Chung H.J.1, Lin A.T-L.1, Huang Y.H.1, Lin C.C.1, Chen T.J.2, Chen K.K.1

Institutes: 1Taipei Veterans General Hospital, Dept. of Urology, Taipei, Taiwan, 2Taipei Veterans General Hospital, Dept. of Family Medicine, Taipei, Taiwan

6
Seeking explanations for the pathogenesis of kidney stones in studies of a relatively stone-free race group

By: Rodgers A.

Institutes: University of Cape Town, Dept. of Chemistry, Cape Town, South Africa

7
Endoscopic description of renal papillary abnormalities in stone disease by flexible ureteroscopy: A proposed classification of severity and type

By: Almeras C.1, Daudon M.2, Ploussard G.3, Gautier J.R.3, Salin A.3, Traxer O.4, Meria P.5

Institutes: 1Clinique Saint Jean Languedoc, Dept. of Urology, Toulouse, France, 2Tenon Hospital, Dept. of Functional Explorations, Paris, France, 3Clinique Saint Jean Languedoc, Dept of Urology, Toulouse, France, 4Tenon Hospital, Dept of Urology, Paris, France, 5Saint Louis Hospital, Dept of Urology, Paris, France

8
Calcium oxalate stone formation: Microstructural evaluation of Randall plaque and the plaque/stone interface

By: Wendt-Nordahl G.1, Sethmann I.2, Enzmann F.3, Simon L.3, Knoll T.1, Klebe H.-J.2

Institutes: 1Klinikum Sindelfingen-Böblingen, Dept. of Urology, Sindelfingen, Germany, 2Technical University Darmstadt, Institut für Angewandte Geowissenschaften, Darmstadt, Germany, 3University Mainz, Institut für Geowissenschaften, Mainz, Germany

10
The association between the gene polymorphisms in the calcium-sensing receptor and calcium nephrolithiasis in Jiangxi Gannan area

By: Guoxi Z., Qingming Z., Xiaofeng Z., Quanliang L., Yijun X., Gengqing W., Xiaoning W., Bo J.

Institutes: Institute of Urology, Gannan Medical University, Dept. of Urology, First Affiliated Hospital of Gannan Medical University, Ganzhou, China

11
Characterizing the association between toll-like receptor types and nephrolithiasis with renal inflammation in an animal model

By: Ölçücü M.T.1, Teke K.1, Yalcin S.1, Olcucuoglu E.2, Caner V.5, Turk N.S.4, Tuncay O.L.3

Institutes: 1Agri State Hospital, Dept. of Urology, Agri, Turkey, 2Türkiye Yuksek Ihtisas Education and Research Hospital, Dept. of Urology, Ankara, Turkey, 3Pamukkale University School of Medicine, Dept. of Urology, Denizli, Turkey, 4Pamukkale University School of Medicine, Dept. of Pathology, Denizli, Turkey, 5Pamukkale University School of Medicine, Dept. of Genetics, Denizli, Turkey

12
A study on the role of SLC26A6 in urolithiasis

By: Jiang H., Wang T., Liu Z., Liu J., Wang S., Ye Z.

Institutes: Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Dept. of Urology, Wuhan, China

13
Optimal management of cystine stone formers: 21-year retrospective follow-up study

By: Moore S.1, Somani B.1, Cook P.2

Institutes: 1University Hospital Southampton, Dept. of Urology, Southampton, United Kingdom, 2University Hospital Southampton, Dept. of Biochemical Pathology, Southampton, United Kingdom

14
Adherence of cystinuric patients to medical prevention treatment and its impact on clinical outcomes

By: Young G.2, Kampantais S.1, Stasinou T.2, Bourdoumis A.3, Chow K.2

Institutes: 1Southend University Hospital, Dept. of Urology, Southend on Sea, United Kingdom, 2University Hospital of South Manchester, Dept. of Urology, Manchester, United Kingdom, 3Pennine Acute Hospitals NHS Trust, Dept. of Urology, Manchester, United Kingdom

15
Environmental melamine exposure increase renal tubular injury in patients with calcium urolithiasis: The possible mechanism of melamine associated urolithiasis formation

By: Liu C-C.1, Wu C-F.2, Hsieh T-J.3, Tsai Y-C.4, Huang S-P.5, Lee Y-C.5, Huang T-Y.5, Chou Y-H.5, Shen J-T.6, Huang C-N.5, Wu W-J.5, Wu M-T.7

Institutes: 1Kaohsiung Medical University Hospital, Kaohsiung Medical University, PingTung Hospital, Dept. of Urology, Kaohsiung/PingTung, Taiwan, 2Kaohsiung Medical University, Dept. of Public Health,College of Health Sciences, Kaohsiung, Taiwan, 3Kaohsiung Medical University, Graduate Institute of Medicine, Kaohsiung, Taiwan, 4Kaohsiung Medical University Hospital, Division of Nephrology, Dept. of Internal Medicine, Kaohsiung, Taiwan, 5Kaohsiung Medical University Hospital, Kaohsiung Medical University, Dept. of Urology, Kaohsiung, Taiwan, 6Kaohsiung Municipal Hsiao-Kang Hospital, Dept. of Urology, Kaohsiung, Taiwan, 7Kaohsiung Medical University, Research Center for Environmental Medicine, Kaohsiung, Taiwan

16
The efficacy of N-acetylcysteine against renal oxidative stress after extracorporeal shock wave treatment: An experimental rat model

By: Baba D.1, Cam K.2, Senoglu Y.3, Yuksel A.4, Basaran E.1, Tekin A.4, Kayıkcı M.A.4, Erdem H.5

Institutes: 1Duzce State Hospital, Dept. of Urology, Duzce, Turkey, 2Marmara University School of Medicine, Dept. of Urology, Istanbul, Turkey, 3Aliaga State Hospital, Dept. of Urology, Izmir, Turkey, 4Duzce University School of Medicine, Dept. of Urology, Duzce, Turkey, 5Ordu University School of Medicine, Dept. of Pathology, Ordu, Turkey